1. Medtech Insight

‘Diagnostics Has Been Underestimated’: COVID-19 Testing Drives Roche Diagnostics Q1 Sales

 
• By Catherine Longworth

Roche's diagnostics sales increased 5% to $2.93bn in the first quarter of 2020. Molecular diagnostics was the main growth contributor, driven by demand for COVID-19 tests and automated testing systems.

Quarterly resluts on typewriter close up
• Source: shutterstock.com

Strong demand for COVID-19 molecular testing drove growth in Roche’s diagnostics division in the first quarter of 2020, the company reported on 22 April.

Overall, Roche’s diagnostic sales increased 5%, year-over-year, to CHF 2.9bn ($2.93bn) in the first quarter. The diagnostics division was led by the 29% growth in molecular diagnostics revenue driven by...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from In Vitro Diagnostics

More from Diagnostics